undefined
Posts
undefined
Followers
New blood test analysis could help doctors spot cancer earlier
By By Talker News,
2025-01-20By Lauren Beavis
A new way of interpreting standard blood tests could help doctors spot cancer warning signs sooner, according to scientists.
Experts believe it could flag 10,000 patients a year who have a raised blood platelet count before their cancer diagnosis - leading to 'earlier diagnosis and better patient outcomes'.
The Royal Devon University Healthcare NHS Foundation Trust (RDUH) is the first Trust to apply this new algorithm - found by scientists at the University of Exeter - to routine blood analysis.
This will mean experts can detect differences in raised blood platelet (tiny blood cells that help the body form clots to stop bleeding) levels in a more tailored way - and flag any concerns to doctors to investigate.
Blood tests already include a platelet count as standard – and a high platelet count can sometimes be an indicator of certain types of cancer, including lung and bowel cancers.
Levels of platelets vary depending on age, and whether a person is male or female, however, this variation is currently not considered when doctors are interpreting platelet count results and deciding whether they might indicate cancer.
Professor Sarah Bailey, Associate Professor of Primary Care Diagnostics at the University of Exeter, said their findings have the potential to save lives.
Sarah, who led the study, explained: “General practitioners know that a raised platelet count can be an early sign of cancer.
"This study will give them more information about when this should be taken as a warning sign, and how to act on it.
"This study paves the way for more tailored interpretation alongside practical advice for GPs about next steps.
"We’re delighted to see it in action in Devon already, and we hope to see it rolled out even further, to benefit patients and potentially save lives.”
When a patient has a blood test at a GP (general practitioner) practice, they are processed through a hospital-based laboratory, explains experts from the University.
In Devon, the RDUH team conducts around 500,000 blood tests that include a platelet reading each year alone.
Initially, the new analysis will be piloted on tests from five practices or medical centers in the county.
In this pilot group, the research team estimates that the new algorithm would flag around 500 patients with raised platelets each year, with around 20 people in that group having cancer that would be caught earlier.'
Where a patient has a high platelet count, the doctor will be notified as part of the results sent back to them.
The system includes providing clear guidance to the doctor on what steps to take next to assess whether the reading warrants further investigation.
Professor Tim McDonald, Clinical Director for Pathology at the Blood Sciences Laboratories at the Royal Devon University Healthcare (RDUH) NHS Foundation Trust, added: “This research really is a win-win for improving cancer diagnosis.
"It’s actually very simple for us to add to the routine tests we’re already conducting, and we hope it will mean that GPs can catch cancer in some patients earlier, which we know leads to the best outcomes.”
The initial pilot is expected to run for two years, including a staged expansion in specific regions.
If this system is then rolled out across the NHS, experts believe it could flag 10,000 patients a year who have a raised blood platelet count before their cancer diagnosis.
Recognition of this early warning sign could lead to earlier diagnosis and better patient outcomes.
The research paper is entitled ' Improving the Clinical Utility of Platelet Count for Cancer Detection in Primary Care: A Cohort Study in England, Canada, and Australia ', and is published in Cancers .